HomeCompareCNVVF vs EPRT

CNVVF vs EPRT: Dividend Comparison 2026

CNVVF yields 2.66% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNVVF wins by $233.26M in total portfolio value
10 years
CNVVF
CNVVF
● Live price
2.66%
Share price
$2.63
Annual div
$0.07
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$233.32M
Annual income
$217,615,015.11
Full CNVVF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — CNVVF vs EPRT

📍 CNVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNVVFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNVVF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNVVF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNVVF
Annual income on $10K today (after 15% tax)
$226.24/yr
After 10yr DRIP, annual income (after tax)
$184,972,762.84/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, CNVVF beats the other by $184,961,848.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNVVF + EPRT for your $10,000?

CNVVF: 50%EPRT: 50%
100% EPRT50/50100% CNVVF
Portfolio after 10yr
$116.69M
Annual income
$108,813,927.91/yr
Blended yield
93.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CNVVF
No analyst data
Altman Z
3.9
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNVVF buys
0
EPRT buys
0
No recent congressional trades found for CNVVF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNVVFEPRT
Forward yield2.66%3.92%
Annual dividend / share$0.07$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%29%
Portfolio after 10y$233.32M$63.4K
Annual income after 10y$217,615,015.11$12,840.73
Total dividends collected$232.13M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CNVVF vs EPRT ($10,000, DRIP)

YearCNVVF PortfolioCNVVF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$11,232$532.32$11,205$505.18+$27.00CNVVF
2$13,136$1,117.60$12,672$682.46+$464.00CNVVF
3$16,499$2,443.06$14,490$930.48+$2.0KCNVVF
4$23,389$5,735.39$16,786$1,282.69+$6.6KCNVVF
5$40,224$15,197.43$19,753$1,791.56+$20.5KCNVVF
6$91,892$48,852.40$23,677$2,541.64+$68.2KCNVVF
7$306,930$208,605.82$29,008$3,672.99+$277.9KCNVVF
8$1,630,788$1,302,372.58$36,463$5,425.08+$1.59MCNVVF
9$14,679,140$12,934,196.98$47,238$8,221.57+$14.63MCNVVF
10$233,321,695$217,615,015.11$63,385$12,840.73+$233.26MCNVVF

CNVVF vs EPRT: Complete Analysis 2026

CNVVFStock

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Full CNVVF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this CNVVF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNVVF vs SCHDCNVVF vs JEPICNVVF vs OCNVVF vs KOCNVVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.